Effect of Shock Wave Therapy on Myofascial Pain Syndrome in Adolescent Athletes

February 20, 2025 updated by: Mohamed Hafez Mohamed, Cairo University
The purpose of the study is to determine the effect of extracorporeal shockwave therapy on pain, neck range of motion, and functional activity in adolescent athletes.

Study Overview

Detailed Description

Myofascial pain syndrome is a syndrome characterized by pain and accompanying muscle spasms, referred pain patterns, stiffness, and restricted range of motion caused by trigger points on constricted fibers of muscles and/or fasciae. Myofascial pain syndrome is the most common reason for back pain, shoulder pain, tension-type headaches, and regional pains such as facial pain.

Myofascial trigger points (MTrPs) are understood as the morphological correlate of the myofascial pain syndrome (MPS), an acute or chronic muscular pain condition affecting a single muscle or a group of muscles. Active MTrPs are spontaneously painful, while latent MTrPs are only painful upon pressure. MTrP stimulation can also cause referred pain and the characteristic local twitch response.

The main goal of MPS treatment is to break down the vicious circle of "spasm - pain - spasm" and release trigger points. Various physical therapy modalities such as trigger point injection, stretching-spray technique or ultrasound (US), heat packs and transcutaneous electrical nerve stimulation (TENS), and extracorporeal shock wave therapy (ESWT), are used for the treatment of MPS. These modalities inactivate the trigger point with their thermal and mechanical effects.

Due to the lack of research area of extracorporeal shock wave therapy on myofascial pain syndrome on upper trapezius in adolescents' athletes, so the purpose of the study is to know impact of the extracorporeal shock wave therapy on myofascial pain syndrome on upper trapezius in adolescents' athletes.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Walaa Abd El Hakeem Abd El Nabi, PhD

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age ranges from 14 to 18 years.
  • All adolescents have regional pain complaint.
  • Tenderness in cervical trigger points in the midpoint of the upper border of the trapezius muscle, from grade 2 to grade 4 according to the tenderness grading scheme (Hubbard, 1993) (Appendix II).
  • Palpation of a trigger point elicits a stereotypic zone of referred pain specific to that muscle.
  • Identification of a palpable taut band, as well as a palpable, and exquisitely tender spot along the length of that taut band.
  • All adolescents are allowed to practice their regular sports activities.

Exclusion Criteria:

  • Dermatological disorders.
  • Having myofascial trigger points injection.
  • Chronic pain in both sides of the body.
  • History of findings of cervical injury whether orthopedic or soft tissue injury.
  • Analgesic drugs or NSAIDs during the treatment period.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Designed physical therapy program
It will consist of 20 adolescents, who will receive a designed physical therapy program for the treatment of Myofascial pain syndrome.
Both groups will receive a designed physical therapy program, in the form of myofascial trigger points pressure release, stretching of the upper trapezius muscle, strengthening exercises, and infrared radiation for 4 weeks.
Experimental: Designed physical therapy program + Extracorporeal shock wave therapy (ESWT)
It will consist of 20 adolescents, who will receive the same designed physical therapy program in addition to extracorporeal shock wave therapy (ESWT).
Both groups will receive a designed physical therapy program, in the form of myofascial trigger points pressure release, stretching of the upper trapezius muscle, strengthening exercises, and infrared radiation for 4 weeks.
Adolescents of the experimental group will receive Extracorporeal shock wave therapy with the following parameters; low-level energy radial extracorporeal shock wave by (STORZ MEDICAL Master Pulse MP200), each subject received 3 sessions per week for 4 weeks with 700 impulse/session 400 impulse was applied to tight band and 300 impulses will be applied surrounding the tight band, with frequency [10HZ], resulting in positive energy flux density [EFD] 0.056mJ/mm.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of pain level
Time Frame: 4 weeks
By Pain Quality Assessment Scale (PQAS), which help to measure different aspects of pain. For one patient, a pain might feel extremely hot and burning, but not at all dull, while another patient may not experience any burning pain, but feel like their pain is very dull and achy. High test-retest reliability has been observed in both literate and illiterate patients with neuropathic pain, for construct validity, was high in patients with chronic pain conditions. The scale creates a 20- item measures that would be even more useful for assessing neuropathic pain and also would be used to assess pain qualities associated with non-neuropathic pain. PQAS can be scored as individual ratings (20 items), or the PQAS items can be combined into composite scores.
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment cervical flexion range of motion (ROM)
Time Frame: 4 weeks
It will be assessed by the CROM instrument pre and post-treatment. The subject should be seated upright in a straight-back chair with the sacrum against the backrest, thoracic spine away, arms at the sides, and feet flat on the floor. The CROM instrument is positioned like a pair of glasses and secured with Velcro straps. To ensure full cervical flexion, the movement begins with a slight nod to create a double chin (suboccipital flexion) before continuing into full flexion. The sagittal plane meter should be read through its beveled edge for an accurate magnified reading, and the measurement is recorded on the designated sheet.
4 weeks
Assessment cervical extension range of motion (ROM)
Time Frame: 4 weeks
It will be assessed by the CROM instrument pre and post-treatment. Cervical extension is measured by initiating a slight backward nod (suboccipital extension), followed by further extension until the full range is reached. The obtained measurement is then recorded accordingly.
4 weeks
Assessment cervical lateral flexion ROM to the right
Time Frame: 4 weeks
It will be assessed by the CROM instrument pre and post-treatment. To prevent rotation during lateral flexion, focus should remain on a fixed point straight ahead. A sagittal plane meter reading of zero confirms a neutral head position, while any deviation on the lateral flexion meter indicates lateral flexion at rest, which should be recorded. Lateral flexion of the head to the right is performed while maintaining level shoulders and avoiding rotation. Shoulder elevation is monitored and corrected manually if needed.
4 weeks
Assessment cervical lateral flexion ROM to the left
Time Frame: 4 weeks
It will be assessed by the CROM instrument pre and post-treatment. To prevent rotation during lateral flexion, focus should remain on a fixed point straight ahead. A sagittal plane meter reading of zero confirms a neutral head position, while any deviation on the lateral flexion meter indicates lateral flexion at rest, which should be recorded. Lateral flexion of the head to the left is performed while maintaining level shoulders and avoiding rotation. Shoulder elevation is monitored and corrected manually if needed.
4 weeks
Assessment cervical rotation ROM to the right
Time Frame: 4 weeks
It will be assessed by the CROM instrument plus the magnetic yoke and rotation arm pre and post-treatment. Accurate readings depend on determining magnetic north by observing the red needle on the rotation meter at least four feet from the yoke. The magnetic yoke is positioned on the subject's shoulders with the arrow pointing north. The subject remains seated upright in a straight-back chair with the sacrum against the backrest, thoracic spine away, arms at the sides, and feet flat. The lateral flexion and sagittal plane meters must read zero to ensure a level rotation meter. With the subject facing forward, the rotation meter is adjusted so one pointer aligns with zero. A fixed horizontal line on the wall serves as a visual reference to prevent head tilting. Rotation to the right occurs first, with the left shoulder lightly stabilized to prevent movement.
4 weeks
Assessment cervical rotation ROM to the left
Time Frame: 4 weeks
It will be assessed by the CROM instrument plus the magnetic yoke and rotation arm pre and post-treatment. Accurate readings depend on determining magnetic north by observing the red needle on the rotation meter at least four feet from the yoke. The magnetic yoke is positioned on the subject's shoulders with the arrow pointing north. The subject remains seated upright in a straight-back chair with the sacrum against the backrest, thoracic spine away, arms at the sides, and feet flat. The lateral flexion and sagittal plane meters must read zero to ensure a level rotation meter. With the subject facing forward, the rotation meter is adjusted so one pointer aligns with zero. A fixed horizontal line on the wall serves as a visual reference to prevent head tilting. Rotation to the left occurs first, with the right shoulder lightly stabilized to prevent movement.
4 weeks
Assessment of functional activity of neck
Time Frame: 4 weeks
It will be assessed pre and post-treatment using the neck disability index (NDI).The 10 items include effects of pain on personal care activities: lifting, reading, sleeping and the patient level of participation in recreational activities. Each section contains 6 statements representing a different level of severity. Each section is scored on a 0 to 5 scale, with 5 designating the greatest disability. The scores of each section are summated for a total score of 50. The total score is then multiplied by 2 to arrive at percentage score. This value represents the percentage of disability.
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Nanees Essam Mohamed Salem, PhD, Professor, Cairo university

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 25, 2025

Primary Completion (Estimated)

April 25, 2025

Study Completion (Estimated)

May 5, 2025

Study Registration Dates

First Submitted

February 20, 2025

First Submitted That Met QC Criteria

February 20, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 20, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myofascial Pain Syndrome

Clinical Trials on Designed physical therapy program

Subscribe